Trial Profile
A double-blind, exploratory phase II study to evaluate the anamorelin for the treatment of cancer cachexia in patients with advanced non small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2015
Price :
$35
*
At a glance
- Drugs Anamorelin (Primary)
- Indications Cachexia; Non-small cell lung cancer
- Focus Therapeutic Use
- 15 Oct 2015 New trial record
- 09 Sep 2015 Results presented at the 16th World Conference on Lung Cancer